title: A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly.
abstract: We examined a family with autosomal-dominant hypertension and brachydactyly from northeastern Turkey. The hypertension was defined as severe, resulting in stroke before age 50 years, featuring normal renin, aldosterone, and catecholamine responses, and did not appear to be salt-sensitive. The responsible gene resides on chromosome 12p. To determine which medications were most effective, we performed a prospective clinical trial. We studied 13 affected individuals in a randomized double-blind, cross-over trial including a beta-blocker (BBL), alpha-blocker (ABL), calcium channel blocker (CCB), converting enzyme inhibitor (CEI), and hydrochlorothiazide (HCT) and placebo (PLA). We then added moxonidine (MOX) and continued the trial for an additional period in a single-blind fashion. Each drug was given for four weeks with an option to double the dose after two weeks; each washout period comprised two weeks. Blood, 24-hour urine, and saliva were studied at the outset, and blood and urine samples were obtained at the end of each phase. Blood pressure (BP) and heart rate measurements were with the patient ambulatory at 24 hours. All regimens required doubled doses at two weeks. Beta blocker, CCB, CEI, and ABL lowered BP (6 to 10 mm Hg) and BP load compared to PLA, while HCT and MOX did not. Converting enzyme inhibitor and HCT increased plasma renin activity (PRA), while BBL lowered PRA. The 24-hour urine analysis indicated a high dietary salt intake with a low potassium and calcium intake. The salivary electrolytes showed similar sodium and potassium concentrations, while chloride values were significantly higher in affected than nonaffected subjects. Thus, this monogenic form of hypertension resembles nonsalt-sensitive essential hypertension in that BBL, CCB, CEI, and ABL were effective, while HCT was not. The BP reduction was similar to other single drug trials in essential hypertension. The high salivary chloride values suggest an additional intermediary phenotype that may be related to electrolyte transport. These results raise the possibility that an as yet unknown hypertensive mechanism is operative in these subjects.
authors.affiliation: Franz Volhard Clinic, Virchow Klinikum, Humboldt University of Berlin, Germany.
authors.forename: H
authors.initials: H
authors.lastname: Schuster
authors.forename: O
authors.initials: O
authors.lastname: Toka
authors.forename: H R
authors.initials: HR
authors.lastname: Toka
authors.forename: A
authors.initials: A
authors.lastname: Busjahn
authors.forename: O
authors.initials: O
authors.lastname: Oztekin
authors.forename: T F
authors.initials: TF
authors.lastname: Wienker
authors.forename: N
authors.initials: N
authors.lastname: Bilginturan
authors.forename: S
authors.initials: S
authors.lastname: Bähring
authors.forename: F
authors.initials: F
authors.lastname: Skrabal
authors.forename: H
authors.initials: H
authors.lastname: Haller
authors.forename: F C
authors.initials: FC
authors.lastname: Luft
mesh_terms: D000293:Adolescent; D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D017880:Limb Deformities, Congenital / Q000235:genetics*; D008297:Male; D015221:Potassium Channels / Q000502:physiology
chemical_list: D015221:Potassium Channels